Condition: Anemia, Iron Deficiency · Sponsor: Johns Hopkins Bloomberg School of Public Health
The World Health Organization (WHO) currently recommends the pregnant women receive iron-containing supplements and, in settings where calcium intake is low, calcium supplements. Supplements are to be taken at two separate times of the day as calcium may interfere with iron absorption. The goal of this clinical trial is to learn whether taking daily calcium supplements and iron-containing multiple micronutrient supplements together, at the same time, has any negative impact on the hemoglobin or iron status of pregnant women or the woman's infants. Participants will be randomly assigned and counseled to either take the supplements together every morning or to take the multiple micronutrient supplement in the morning and the calcium supplement in the evening. Participants will visit the antenatal clinic monthly and be asked to provide a blood sample in early, mid, and late pregnancy. Researchers will also take blood samples from infants at the time of birth.
This description comes directly from the study's public registry record.
Amanda C Palmer, PhD · 1 (410) 955-2061 · acpalmer@jhu.edu
Monica Pasqualino, PhD · mpasqua2@jhmi.edu
Always discuss trial participation with your own doctor first.
| Institut Africain de Santé Publique (African Institute of Public Health) | Ouagadougou, Burkina Faso | Recruiting |
| Aga Khan University | Karachi, Pakistan | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06568315